Modern view on hemostasis system: cell theory

For many years, there has been no model capable of explaining the complex processes of interaction between various bloodclotting factors leading to a stop of bleeding. One of the most successful models able to partially reflect the mechanisms of hemostasis for a long time was the cascade theory. The cascade model perfectly explains the processes occurring during coagulation in vitro, but was completely inadequate in attempts to evaluate the processes occurring in vivo. A significant drawback of the cascade model is the impossibility to trace the interaction of cells carrying the tissue factor, platelets and plasma coagulation factors on their surface, since these conditions cannot be imitated. The cell theory, which has replaced the cascade theory, pays attention not only to the interaction of plasma coagulation factors, but also takes into account the role of platelets as important participants of coagulation processes. It is based on a four-stage reaction cascade that includes the following stages: initiation, amplification, propagation, and termination.

The cell theory of hemostasis is able to reflect the complex process of interaction of all the links of hemostasis and answer questions related to the problems in patients with disorders of the coagulation system. The cell theory of hemostasis allows to reflect more precisely the processes of hemostasis in vivo and to interpret correctly the results of tests and pathophysiological mechanisms of disorders of the coagulation system. Global tests (thrombin generation assay, thromboelastography, thrombodynamics) used for hemostasis system evaluation are more complimentary with cell theory of hemostasis.

1. Nichols W.L. & Bowie E.J. (Eds). A history of blood coagulation: Charles A. Owen, Jr. Rochester, MN: Mayo Foundation for Medical Education and Research; 2001. Available at: https://www.worldcat.org/title/history-ofblood-coagulation/oclc/48480053.

2. Hoffman M., Monroe D.M. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958– 65. doi: 10.1055/s-0037-1615947.

3. Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science. 1964;145(3638):1310–2. doi: 10.1126/science.145.3638.1310.

4. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 1964;202:498– 9. doi: 10.1038/202498a0.

5. Mann K.G., Brummel-Ziedins K., Orfeo T., Butenas S. Models of blood coagulation. Blood Cells Mol Dis. 2006;36(2):108–17. doi: 10.1016/j. bcmd.2005.12.034.

6. Lämmle B., Wuillemin W.A., Huber I., Krauskopf M., Zürcher C., Pflugshaupt R., Furlan M. Thromboembolism and bleeding tendency in congenital factor XII deficiency–a study on 74 subjects from 14 Swiss families. Thromb Haemost. 1991;65(2):117–21. doi: 10.1055/s-0038-1647467.

7. Gailani D., Renné T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost JTH. 2007;5(6):1106–12. doi: 10.1111/j.1538-7836.2007.02446.x.

8. Smith S.A. The cell-based model of coagulation. Journal of Veterinary Emergency and Critical Care. 2009;19(1):3–10. doi: 10.1111/j.1476-4431.2009.00389.x.

9. Cawthern K.M., van‘t Veer C., Lock J.B., DiLorenzo M.E., Branda R.F., Mann K.G. Blood Coagulation in Hemophilia A and Hemophilia C. Blood. 1998;91(12):4581-4592. Available at: https:// www.ncbi.nlm.nih.gov/pubmed/9616154.

10. Ferreira C.N., Sousa M.O., Dusse L.M.S., Carvalho M.G. A cell-based model of coagulation and its implications. Rev Bras Hematol Hemoter. 2010;32(5):416-421. doi: 10.1590/S1516- 84842010000500016

11. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16(1/2):17- 20. doi: 10.1023/B:THRO.0000014588.95061.28.

12. Osterud B., Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977;74(12):5260–4. doi: 10.1073/ pnas.74.12.5260.

13. Monroe D.M., Hoffman M, Roberts H.R. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets. Blood Coagul Fibrinolysis. 1996;7:459-464. Available at: https://europepmc.org/abstract/med/8839998.

14. Hultin M.B. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets. Blood. 1985;66:53- 58. Available at: https://www.ncbi.nlm.nih.gov/ pubmed/3924141.

15. Heemskerk J.W.M., Bevers E.M., Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002 Aug;88(2):186–93. doi: 10.1055/s-0037-1613209.

16. Riddel Jr J.P., Aouizerat B.E., Miaskowski C., Lillicrap D.P. Theories of blood coagulation. J Pediatr Oncol Nurs. 2007;24(3):123-31. doi: 10.1177/1043454206298693.

17. Ariëns R.A., Lai T., Weisel J.W., Greenberg C.S., & Grant P.J. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100(3):743-754. doi: 10.1182/ blood.V100.3.743.

18. Malý M.A., Tomasov P., Hájek P., Blasko P., Hrachovinová I., Salaj P., Veselka J. The role of tissue factor in thrombosis and hemostasis. Physiol Res. 2007;56(6):685-695. Available at: https:// www.ncbi.nlm.nih.gov/pubmed/17087602.

19. Valen G., Sigurdardottir O., Vaage J. Systemic release of thrombomodulin, but not from the cardioplegic, reperfused heart during open heart surgery. Thromb Res. 1996;83(4):321-8. doi: 10.1016/0049-3848(96)00140-5.